Similar articles

• Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.

  Slavin S, Or R, Naparstek E, Weiss L, Mumcuoglu M, Weshler Z, Brautbar H, Cividalli G, Glikson M, Hale G, et al. Slavin S, et al. Transplant Proc. 1987 Feb;19(1 Pt 3):2614-5. Transplant Proc. 1987. PMID: 3274569 No abstract available.
• Bone marrow transplantation: past experiences and future prospects.

  Thomas ED. Thomas ED. Semin Oncol. 1992 Jun;19(3 Suppl 7):3-6. Semin Oncol. 1992. PMID: 1615331 Review. No abstract available.
• Complications in early posttransplantation period in the patients with allogenic and autological bone marrow transplantation.

  Lubimova LS, Fainstein FE. Lubimova LS, et al. Folia Haematol Int Mag Klin Morphol Blutforsch. 1989;116(3-4):581-3. Folia Haematol Int Mag Klin Morphol Blutforsch. 1989. PMID: 2480312 No abstract available.
• [Allogeneic bone marrow graft in children].

  Fischer A, Griscelli C. Fischer A, et al. Arch Fr Pediatr. 1986 Jan;43(1):3-8. Arch Fr Pediatr. 1986. PMID: 3085626 Review. French. No abstract available.
• Bone marrow transplantation. The state of the art.

  Thomas ED. Thomas ED. Ann Ital Med Int. 1986 Jun;1(2):109-14. Ann Ital Med Int. 1986. PMID: 3079358 Review. No abstract available.